AQST Financial Statements

Balance sheet, income statement, cash flow, and dividends for Aquestive Therapeutics Inc (AQST).


$324.59M Market Cap.

As of 03/05/2025 5:00 PM ET (MRY) • Disclaimer

AQST Market Cap. (MRY)


AQST Shares Outstanding (MRY)


AQST Assets (MRY)


Total Assets

$101.42M

Total Liabilities

$161.58M

Total Investments

$0

AQST Income (MRY)


Revenue

$57.56M

Net Income

-$44.14M

Operating Expense

$70.46M

AQST Cash Flow (MRY)


CF Operations

-$35.76M

CF Investing

-$159.00K

CF Financing

$83.59M

AQST Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

AQST Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$101,424,000 (76.64%)

$57,418,000 (0.61%)

$57,070,000 (-7.94%)

$61,993,000 (-1.42%)

Assets Current

$88,220,000 (115.35%)

$40,966,000 (2.70%)

$39,888,000 (-15.60%)

$47,259,000 (5.90%)

Assets Non-Current

$13,204,000 (-19.74%)

$16,452,000 (-4.25%)

$17,182,000 (16.61%)

$14,734,000 (-19.31%)

Goodwill & Intangible Assets

$0 (0%)

$1,278,000 (-10.94%)

$1,435,000 (2713.73%)

$51,000 (-50.00%)

Shareholders Equity

-$60,156,000 (43.51%)

-$106,487,000 (10.18%)

-$118,554,000 (-44.34%)

-$82,134,000 (-69.36%)

Property Plant & Equipment Net

$8,981,000 (-7.75%)

$9,736,000 (4.73%)

$9,296,000 (19.49%)

$7,780,000 (-24.62%)

Cash & Equivalents

$71,546,000 (199.71%)

$23,872,000 (-12.47%)

$27,273,000 (-2.68%)

$28,024,000 (-11.89%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$21,053,000 (-37.89%)

$33,896,000 (2.93%)

$32,930,000 (317.52%)

$7,887,000 (82.32%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$6,044,000 (-10.71%)

$6,769,000 (17.11%)

$5,780,000 (43.14%)

$4,038,000 (64.08%)

Trade & Non-Trade Receivables

$7,344,000 (-13.30%)

$8,471,000 (80.08%)

$4,704,000 (-61.19%)

$12,120,000 (74.26%)

Trade & Non-Trade Payables

$10,287,000 (15.25%)

$8,926,000 (-10.26%)

$9,946,000 (19.63%)

$8,314,000 (17.28%)

Accumulated Retained Earnings (Deficit)

-$363,214,000 (-13.83%)

-$319,077,000 (-2.53%)

-$311,207,000 (-21.19%)

-$256,796,000 (-37.87%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$121,851,000 (8.24%)

$112,570,000 (-8.29%)

$122,747,000 (5.18%)

$116,705,000 (30.47%)

Debt Current

$1,536,000 (15.14%)

$1,334,000 (-93.36%)

$20,102,000 (384.50%)

$4,149,000 (-12.71%)

Debt Non-Current

$120,315,000 (8.16%)

$111,236,000 (8.37%)

$102,645,000 (-8.81%)

$112,556,000 (32.89%)

Total Liabilities

$161,580,000 (-1.42%)

$163,905,000 (-6.67%)

$175,624,000 (21.85%)

$144,127,000 (29.40%)

Liabilities Current

$18,865,000 (3.04%)

$18,308,000 (-53.68%)

$39,528,000 (79.97%)

$21,964,000 (4.08%)

Liabilities Non-Current

$142,715,000 (-1.98%)

$145,597,000 (6.98%)

$136,096,000 (11.41%)

$122,163,000 (35.32%)

AQST Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$57,561,000 (13.80%)

$50,583,000 (6.09%)

$47,680,000 (-6.20%)

$50,832,000 (10.87%)

Cost of Revenue

$17,872,000 (-14.20%)

$20,831,000 (7.45%)

$19,386,000 (29.33%)

$14,989,000 (15.62%)

Selling General & Administrative Expense

$50,180,000 (58.05%)

$31,750,000 (-39.96%)

$52,879,000 (-1.11%)

$53,475,000 (-4.32%)

Research & Development Expense

$20,280,000 (54.76%)

$13,104,000 (-25.04%)

$17,481,000 (2.55%)

$17,047,000 (-14.28%)

Operating Expenses

$70,460,000 (57.09%)

$44,854,000 (-36.25%)

$70,360,000 (-0.23%)

$70,522,000 (-6.94%)

Interest Expense

$16,817,000 (125.37%)

$7,462,000 (-40.03%)

$12,443,000 (-44.60%)

$22,461,000 (72.49%)

Income Tax Expense

-$14,000 (-105.71%)

$245,000 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$44,137,000 (-460.83%)

-$7,870,000 (85.54%)

-$54,410,000 (22.87%)

-$70,539,000 (-26.45%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$44,137,000 (-460.83%)

-$7,870,000 (85.54%)

-$54,410,000 (22.87%)

-$70,539,000 (-26.45%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$44,137,000 (-460.83%)

-$7,870,000 (85.54%)

-$54,410,000 (22.87%)

-$70,539,000 (-26.45%)

Weighted Average Shares

$86,726,211 (41.58%)

$61,255,864 (25.69%)

$48,734,377 (27.99%)

$38,077,660 (13.15%)

Weighted Average Shares Diluted

$86,726,211 (41.58%)

$61,255,864 (25.69%)

$48,734,377 (27.99%)

$38,077,660 (13.15%)

Earning Before Interest & Taxes (EBIT)

-$27,334,000 (-16669.33%)

-$163,000 (99.61%)

-$41,967,000 (12.71%)

-$48,078,000 (-12.43%)

Gross Profit

$39,689,000 (33.40%)

$29,752,000 (5.15%)

$28,294,000 (-21.06%)

$35,843,000 (8.99%)

Operating Income

-$30,771,000 (-103.75%)

-$15,102,000 (64.10%)

-$42,066,000 (-21.30%)

-$34,679,000 (19.15%)

AQST Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$159,000 (84.02%)

-$995,000 (60.58%)

-$2,524,000 (-176.45%)

-$913,000 (-76.60%)

Net Cash Flow from Financing

$83,592,000 (2003.47%)

$3,974,000 (-65.63%)

$11,562,000 (-61.60%)

$30,109,000 (5.81%)

Net Cash Flow from Operations

-$35,759,000 (-460.49%)

-$6,380,000 (34.82%)

-$9,789,000 (70.32%)

-$32,979,000 (27.45%)

Net Cash Flow / Change in Cash & Cash Equivalents

$47,674,000 (1501.76%)

-$3,401,000 (-352.86%)

-$751,000 (80.15%)

-$3,783,000 (78.41%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$159,000 (84.02%)

-$995,000 (60.58%)

-$2,524,000 (-176.45%)

-$913,000 (-76.60%)

Issuance (Repayment) of Debt Securities

-$23,000 (99.83%)

-$13,274,000 (-555.51%)

-$2,025,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$84,721,000 (390.88%)

$17,259,000 (27.00%)

$13,590,000 (-54.88%)

$30,123,000 (384.68%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$7,099,000 (164.00%)

$2,689,000 (-38.62%)

$4,381,000 (-35.75%)

$6,819,000 (3.62%)

Depreciation Amortization & Accretion

$718,000 (-46.62%)

$1,345,000 (-43.65%)

$2,387,000 (-19.47%)

$2,964,000 (-13.91%)

AQST Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

69.00% (17.35%)

58.80% (-0.84%)

59.30% (-15.89%)

70.50% (-1.67%)

Profit Margin

-76.70% (-391.67%)

-15.60% (86.33%)

-114.10% (17.80%)

-138.80% (-14.05%)

EBITDA Margin

-46.20% (-2108.70%)

2.30% (102.77%)

-83.00% (6.53%)

-88.80% (-3.50%)

Return on Average Equity (ROAE)

99.50% (1244.59%)

7.40% (-85.85%)

52.30% (-54.04%)

113.80% (-35.12%)

Return on Average Assets (ROAA)

-38.50% (-187.31%)

-13.40% (86.34%)

-98.10% (10.98%)

-110.20% (-19.14%)

Return on Sales (ROS)

-47.50% (-15733.33%)

-0.30% (99.66%)

-88.00% (6.98%)

-94.60% (-1.39%)

Return on Invested Capital (ROIC)

-20.60% (-20500.00%)

-0.10% (99.71%)

-34.10% (19.39%)

-42.30% (17.86%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-6.98 (55.08%)

-15.54 (-1830.19%)

-0.81 (61.72%)

-2.1 (34.75%)

Price to Sales Ratio (P/S)

5.36 (119.30%)

2.45 (165.29%)

0.92 (-68.36%)

2.91 (-25.80%)

Price to Book Ratio (P/B)

-5.4 (-325.89%)

-1.27 (-207.52%)

-0.41 (78.34%)

-1.9 (48.72%)

Debt to Equity Ratio (D/E)

-2.69 (-74.53%)

-1.54 (-3.92%)

-1.48 (15.61%)

-1.75 (23.60%)

Earnings Per Share (EPS)

-0.51 (-292.31%)

-0.13 (88.39%)

-1.12 (39.46%)

-1.85 (-11.45%)

Sales Per Share (SPS)

0.66 (-19.61%)

0.83 (-15.54%)

0.98 (-26.74%)

1.33 (-1.98%)

Free Cash Flow Per Share (FCFPS)

-0.41 (-245.00%)

-0.12 (52.57%)

-0.25 (71.57%)

-0.89 (34.85%)

Book Value Per Share (BVPS)

-0.69 (60.07%)

-1.74 (28.57%)

-2.43 (-12.80%)

-2.16 (-49.69%)

Tangible Assets Book Value Per Share (TABVPS)

1.17 (27.62%)

0.92 (-19.79%)

1.14 (-29.81%)

1.63 (-12.81%)

Enterprise Value Over EBIT (EV/EBIT)

-13 (99.03%)

-1,347 (-33575.00%)

-4 (20.00%)

-5 (0.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-13.76 (-107.41%)

185.69 (4982.72%)

-3.8 (24.41%)

-5.03 (13.47%)

Asset Turnover

0.5 (-41.63%)

0.86 (0.00%)

0.86 (8.31%)

0.79 (4.47%)

Current Ratio

4.68 (108.94%)

2.24 (121.80%)

1.01 (-53.11%)

2.15 (1.75%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$35,918,000 (-387.02%)

-$7,375,000 (40.10%)

-$12,313,000 (63.67%)

-$33,892,000 (26.28%)

Enterprise Value (EV)

$366,135,367 (66.81%)

$219,485,912 (45.83%)

$150,509,140 (-33.69%)

$226,980,069 (-0.71%)

Earnings Before Tax (EBT)

-$44,151,000 (-479.03%)

-$7,625,000 (85.99%)

-$54,410,000 (22.87%)

-$70,539,000 (-26.45%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$26,616,000 (-2351.78%)

$1,182,000 (102.99%)

-$39,580,000 (12.27%)

-$45,114,000 (-14.74%)

Invested Capital

$132,864,000 (5.01%)

$126,530,000 (13.40%)

$111,581,000 (-13.27%)

$128,659,000 (29.54%)

Working Capital

$69,355,000 (206.09%)

$22,658,000 (6193.89%)

$360,000 (-98.58%)

$25,295,000 (7.54%)

Tangible Asset Value

$101,424,000 (80.66%)

$56,140,000 (0.91%)

$55,635,000 (-10.18%)

$61,942,000 (-1.34%)

Market Capitalization

$324,594,367 (140.67%)

$134,869,912 (176.07%)

$48,854,140 (-68.73%)

$156,238,069 (-13.14%)

Average Equity

-$44,339,000 (58.30%)

-$106,325,000 (-2.27%)

-$103,968,250 (-67.66%)

-$62,011,500 (-94.95%)

Average Assets

$114,627,500 (94.99%)

$58,786,250 (6.04%)

$55,438,500 (-13.41%)

$64,021,000 (6.11%)

Invested Capital Average

$132,524,000 (16.33%)

$113,919,000 (-7.34%)

$122,946,500 (8.23%)

$113,592,750 (36.82%)

Shares

91,178,193 (36.56%)

66,767,283 (23.29%)

54,156,014 (34.84%)

40,164,028 (19.47%)